Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5909 Target Snapshot

Hypoxia-inducible factor 1-alpha inhibitor · SINGLE PROTEIN · Homo sapiens

95Compounds
19Assays
2Approved Drugs
96.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9NWT6. Use UniProt Q9NWT6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9NWT6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Hypoxia-inducible factor 1-alpha inhibitor as ChEMBL target CHEMBL5909, mapped to UniProt Q9NWT6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Hypoxia-inducible factor 1-alpha inhibitor
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5909
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9NWT6
Hypoxia-inducible factor 1-alpha inhibitor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Hypoxia-inducible factor 1-alpha inhibitor is the right protein anchor across sources, using UniProt Q9NWT6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHypoxia-inducible factor 1-alpha inhibitor
UniProt AccessionQ9NWT6
Component TypeProtein
Sequence Length349 aa

Hypoxia-inducible factor 1-alpha inhibitor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Hypoxia-inducible factor 1-alpha inhibitor, mapped to UniProt Q9NWT6. Sequence length is 349 aa.

Mapped IDQ9NWT6
Review nameHypoxia-inducible factor 1-alpha inhibitor
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
1
Phase II
Assay Mix

Activity Type Distribution

IC5092.0
KI3.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL316034 5.96 IC50 1100.0 Preclinical
CHEMBL5404184 5.62 IC50 2380.0 Preclinical
CHEMBL5418688 5.62 IC50 2380.0 Preclinical
CHEMBL5410721 5.53 IC50 2970.0 Preclinical
CHEMBL5410158 5.48 IC50 3310.0 Preclinical
CHEMBL5426884 5.44 IC50 3600.0 Preclinical
CHEMBL5436718 5.44 IC50 3600.0 Preclinical
CHEMBL5437483 5.42 IC50 3780.0 Preclinical
CHEMBL5091848 5.4 IC50 4000.0 Preclinical
CHEMBL5421814 5.4 IC50 3990.0 Preclinical
Distribution

pChEMBL Value Distribution

21
5.0
4
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

19
Total Assays
71
Tested Compounds
1
Assay Types
Binding — 19 assays, 71 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 14 42 4.6
assay format 3 4 4.2
cell-based format 2 25 5.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine